Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mansoor Husain

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Diabetes, Obesity & Metabolism|January 7, 2020
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular riskMansoor Husain, Stephen C Bain, Ole K Jeppesen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 9, 2024
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6Stephen C Bain, Nicolas Belmar, Søren T Hoff, et al.
American Heart Journal|May 17, 2011
Cardiovascular outcomes are predicted by exercise-stress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization proceduresDouglas S Lee, Flavia Verocai, Mansoor Husain, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 16, 2024
Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic reviewArun J Sanyal, Mansoor Husain, Crystel Diab, et al.
Frontiers in Cardiovascular Medicine|June 6, 2022
Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent DifferencesSadi Loai, Xuetao Sun, Mansoor Husain, et al.
Circulation Research|February 19, 2005
A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasiaMourad Toporsian, Robert Gros, Mohammed G Kabir, et al.
Heart Rhythm|June 7, 2024
Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside reviewPraloy Chakraborty, Stanley Nattel, Kumaraswamy Nanthakumar, et al.
Diabetes|January 26, 2010
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in miceMeghan Sauvé, Kiwon Ban, M Abdul Momen, et al.
Circulation Research|March 5, 2011
Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formationSonya Hui, Jaehyun Choi, Syed Zaidi, et al.
Circulation|January 14, 2004
Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in miceLi L Yang, Robert Gros, M Golam Kabir, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Diabetes, Obesity & Metabolism|January 7, 2020
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular riskMansoor Husain, Stephen C Bain, Ole K Jeppesen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 9, 2024
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6Stephen C Bain, Nicolas Belmar, Søren T Hoff, et al.
American Heart Journal|May 17, 2011
Cardiovascular outcomes are predicted by exercise-stress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization proceduresDouglas S Lee, Flavia Verocai, Mansoor Husain, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 16, 2024
Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic reviewArun J Sanyal, Mansoor Husain, Crystel Diab, et al.
Frontiers in Cardiovascular Medicine|June 6, 2022
Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent DifferencesSadi Loai, Xuetao Sun, Mansoor Husain, et al.
Circulation Research|February 19, 2005
A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasiaMourad Toporsian, Robert Gros, Mohammed G Kabir, et al.
Heart Rhythm|June 7, 2024
Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside reviewPraloy Chakraborty, Stanley Nattel, Kumaraswamy Nanthakumar, et al.
Diabetes|January 26, 2010
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in miceMeghan Sauvé, Kiwon Ban, M Abdul Momen, et al.
Circulation Research|March 5, 2011
Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formationSonya Hui, Jaehyun Choi, Syed Zaidi, et al.
Circulation|January 14, 2004
Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in miceLi L Yang, Robert Gros, M Golam Kabir, et al.
Pageof 14